QA: Paratek Pharmaceuticals Inc in us_pharma/2013

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001178711_2014_Paratek_Pharmaceuticals_Inc.pdf

Logs

warning The stock price does not exist industry.us_generic {}

Graph

Absolute values for 0001178711, Paratek Pharmaceuticals Inc

  xvar xval
0 AssetsCurrent 73,627,000
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 43,000
3 remainder_Assets 0
4 LiabilitiesCurrent 1,928,000
5 LiabilitiesNoncurrent 0
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 12,431,000
9 ResearchAndDevelopmentExpense 6,904,000
10 remainder_Expenses 2,962,000
11 remainder_Revenues -5,074,000
12 remainder_NetIncome -75,000
13 remainder_ComprehensiveNetIncome 15,000
  yvar yval
0 Assets 73,670,000
1 Liabilities 1,928,000
2 Expenses 22,297,000
3 Revenues -5,074,000
4 StockholdersEquity 71,742,000
5 NetIncome -27,446,000
6 ComprehensiveNetIncome -27,438,500
7 BaseVar 51,529,500
8 EconomicCapitalRatiobeforeLimitedLiability 3.41
9 EconomicCapitalRatio 3.97

Edgar->Model Mapping

Feature Distribution

Change over Time